Identify Tomorrow’s Blockbusters Today!
In this annual report, with a new, easy to read format, PharmaLive editors detail information about prescription drugs in development and on the market in the United States, including new chemical entities, indications and formulations.
The drugs are separated into sections by their approved or development status. Each section provides the product’s commercial name or product code, chemical or substance composition, the approved or intended application, and developer with company website.
Also included in the report is a chart of the top R&D spenders in 2007, and the number of drugs in development by therapeutic category.
New to this year’s report:
•Comprehensive listing of companies with the therapeutic category(s) they’re developing
•Comparison of this year’s top ten therapeutic categories to last year’s top ten therapeutic categories